Aethlon Medical (AEMD) Stock Price, Quote & News

Company Profile

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening viral infectious, diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Industry: Medical Devices

Sector: Healthcare

Phone: 619 941 0360

Fax: 619 941 0361

Website: www.aethlonmedical.com

Address:

11555 Sorrento Valley Road, Suite 203, San Diego, United States

WKeauhou Aug. 3 at 9:37 AM

$AEMD

0 · Reply

MGeronimo Jul. 30 at 1:22 PM

$AEMD added at 1.23 should bounce back off support

0 · Reply

Chiraya Jul. 28 at 8:14 PM

$AEMD

0 · Reply

NachoBusiness Jul. 24 at 8:16 PM

$AEMD Long 1.36

0 · Reply

MGeronimo Jul. 22 at 2:20 PM

$AEMD IN AT 1.34 5x normal buying

0 · Reply

Francepants06 Jul. 21 at 8:32 PM

$AEMD Wrong ticker

0 · Reply

Quacks206 Jul. 17 at 3:57 PM

$AEMD looking for a 1.28 break

1 · Reply

ZacksSCR Jul. 17 at 3:33 PM

$AEMD: No SAEs in Cohort 1 Post-Hemopurifier Treatment; Progressing Trial to Cohort 2 https://buff.ly/jY57yBs

0 · Reply

OPTIONTURD Jul. 16 at 5:04 PM

$AEMD New approval.....https://www.biospace.com/press-releases/aethlon-medical-inc-announces-positive-data-safety-monitoring-board-review-and-recommendation-to-advance-to-next-clinical-trial-cohort#:~:text=(Nasdaq%3A%20AEMD)%2C%20a,2022%2D06%20has%20completed%20its

0 · Reply

UNCLE_SCROOGE_ Jul. 15 at 7:27 PM

$AEMD Be very careful about buying into this scam; they thrive on news, with no large-scale data. Be wary of this age-old scam; it only features in vitro studies, never tangible numbers. Furthermore, they have no money to do anything. This news is spread specifically to lure people in and rip off as much money as possible, because it will only dilute the profits.

2 · Reply

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Jun 26, 2025, 7:35 PM EDT - 5 weeks ago

Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript

Jun 26, 2025, 4:15 PM EDT - 5 weeks ago

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Jun 20, 2025, 8:01 AM EDT - 6 weeks ago

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Jun 18, 2025, 8:01 AM EDT - 6 weeks ago

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Jun 9, 2025, 8:01 AM EDT - 7 weeks ago

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

May 14, 2025, 8:01 AM EDT - 2 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Mar 10, 2025, 8:01 AM EDT - 5 months ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Feb 13, 2025, 8:01 AM EST - 6 months ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 12, 2025, 8:11 PM EST - 6 months ago

Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript

Feb 12, 2025, 4:15 PM EST - 6 months ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 5, 2025, 8:01 AM EST - 6 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Jan 29, 2025, 8:01 AM EST - 6 months ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Dec 20, 2024, 8:01 AM EST - 8 months ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Nov 14, 2024, 8:00 AM EST - 9 months ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 13, 2024, 7:58 PM EST - 9 months ago

Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript

Nov 13, 2024, 4:15 PM EST - 9 months ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 12, 2024, 8:00 AM EST - 9 months ago

Innovative Medical Technology Advances with First Patient Enrollments

Nov 11, 2024, 8:01 AM EST - 9 months ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 6, 2024, 8:01 AM EST - 9 months ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Oct 8, 2024, 8:01 AM EDT - 10 months ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 19, 2024, 10:00 AM EDT - 11 months ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 8:01 AM EDT - 11 months ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 17, 2024, 8:01 AM EDT - 11 months ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 7:30 AM EDT - 11 months ago

Innovation Driving Cancer's Solid Tumors Market

Sep 16, 2024, 8:01 AM EDT - 11 months ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 13, 2024, 8:35 AM EDT - 11 months ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aug 27, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 14, 2024, 6:45 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q1 2025 Earnings Call Transcript

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 12, 2024, 9:01 AM EDT - 1 year ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 6, 2024, 9:12 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Jun 27, 2024, 6:37 PM EDT - 1 year ago

Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript

Jun 27, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 21, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 20, 2024, 7:00 AM EDT - 1 year ago

What's Next in Treatments for Cancer Patients with Solid Tumors?

Jun 18, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial

Jun 7, 2024, 8:00 AM EDT - 1 year ago

The Hunt for Virus Treatments Continues Post Covid-19

Jun 3, 2024, 9:05 AM EDT - 1 year ago

Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID

Jun 3, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

May 15, 2024, 9:15 AM EDT - 1 year ago

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

May 10, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Feb 21, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Feb 14, 2024, 9:17 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q3 2024 Earnings Call Transcript

Feb 14, 2024, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Feb 7, 2024, 8:00 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

Nov 14, 2023, 10:01 PM EST - 1 year ago

Aethlon Medical, Inc. (AEMD) Q2 2024 Earnings Call Transcript

Nov 14, 2023, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update

Nov 13, 2023, 8:01 AM EST - 1 year ago

Aethlon Medical Announces Appointment of James B. Frakes, M.B.A.

WKeauhou Aug. 3 at 9:37 AM

$AEMD

0 · Reply

MGeronimo Jul. 30 at 1:22 PM

$AEMD added at 1.23 should bounce back off support

0 · Reply

Chiraya Jul. 28 at 8:14 PM

$AEMD

0 · Reply

NachoBusiness Jul. 24 at 8:16 PM

$AEMD Long 1.36

0 · Reply

MGeronimo Jul. 22 at 2:20 PM

$AEMD IN AT 1.34 5x normal buying

0 · Reply

Francepants06 Jul. 21 at 8:32 PM

$AEMD Wrong ticker

0 · Reply

Quacks206 Jul. 17 at 3:57 PM

$AEMD looking for a 1.28 break

1 · Reply

ZacksSCR Jul. 17 at 3:33 PM

$AEMD: No SAEs in Cohort 1 Post-Hemopurifier Treatment; Progressing Trial to Cohort 2 https://buff.ly/jY57yBs

0 · Reply

OPTIONTURD Jul. 16 at 5:04 PM

0 · Reply

UNCLE_SCROOGE_ Jul. 15 at 7:27 PM

2 · Reply

_ICEMAN Jul. 15 at 7:24 PM

$AEMD I keep buying this

0 · Reply

LegendaryCowboy Jul. 15 at 6:29 PM

$AEMD news was good

0 · Reply

Finanz Jul. 15 at 2:25 PM

$AEMD https://www.aethlonmedical.com/news-media/press-releases/detail/506/aethlon-medical-inc-announces-positive-data-safety

0 · Reply

Harley18 Jul. 15 at 12:42 PM

$AEMD what was that

0 · Reply

Quacks206 Jul. 15 at 12:31 PM

$AEMD gets positive news, pops 40% and then slams back down. Float is so small this should run without much effort

1 · Reply

PatJo Jul. 15 at 12:06 PM

$AEMD https://uk.finance.yahoo.com/news/aethlon-medical-inc-announces-positive-120100822.html

0 · Reply

OPTIONTURD Jul. 15 at 12:04 PM

$AEMD Good News....https://www.aethlonmedical.com/news-media/press-releases/detail/506/aethlon-medical-inc-announces-positive-data-safety

0 · Reply

ElginOnStocktwits Jul. 14 at 4:46 PM

$NCNA - like I said yesterday: mid-to-low .04’s… if it drops to .03’s I’m definitely back in to swing up. Watching for now. $LFWD - wants to gap up. Needs volume. $TNFA $WLGS $AEMD - watching 👀

0 · Reply

Peachtreegal Jul. 14 at 3:35 PM

$AEMD. Whoever it was that said that this stock was going to curl its way back up to 5 It is way wrong.

0 · Reply

Love_To_Learn Jul. 14 at 1:07 PM

$HKIT $HWH $AEMD $HUBC ! executing all changes

0 · Reply

Harley18 Jul. 13 at 9:49 PM

$AEMD dam it’s quite

0 · Reply

Quacks206 Jul. 10 at 7:24 PM

$AEMD looks bottomed

0 · Reply

Market Cap	3.00M
Revenue (ttm)	0.00
Net Income (ttm)	-13.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	67,300
Avg Vol	301,259
Day's Range	N/A - N/A
Shares Out	2.59M
Stochastic %K	17%
Beta	1.72
Analysts	Hold
Price Target	$3.02